Human Immunodeficiency Virus Diagnostics: Current Recommendations and Opportunities for Improvement.
Infect Dis Clin North Am. 2019 Jun 22;:
Authors: Branson BM
Profound changes in technology have revolutionized laboratory testing for human immunodeficiency virus (HIV) since the first laboratory enzyme immunoassays that detected only immunoglobulin G (IgG) antibodies. Instrumented fourth-generation random-access chemiluminescent assays are now recommended for initial screening because they become reactive in as little as 2 weeks after infection. Using HIV-1 RNA viral load assays after a reactive initial test could confirm infection and provide useful clinical information. Early initiation of antiretroviral therapy and use of preexposure prophylaxis can alter the evolution of biomarkers and assay reactivity, leading to ambiguous test results.
PMID: 31239094 [PubMed - as supplied by publisher]